Innoviva Inc. (INVA) Financial Statements (2024 and earlier)

Company Profile

Business Address 1350 OLD BAYSHORE HIGHWAY
BURLINGAME, CA 94010
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments291,049201,525246,487350,845114,908129,075
Cash and cash equivalents291,049201,525246,487278,09662,41773,336
Short-term investments    72,74952,49155,739
Receivables54,672110,71193,93179,42783,28670,540
Inventory, net of allowances, customer advances and progress billings55,897     
Inventory55,897     
Other current assets2,933     
Other undisclosed current assets38,9601,4371,640962849754
Total current assets:443,511313,673342,058431,234199,043200,369
Noncurrent Assets
Operating lease, right-of-use asset3,265   
Property, plant and equipment170122833160209
Long-term investments and receivables403,013483,845438,258   
Long-term investments403,013483,845438,258   
Intangible assets, net (including goodwill)279,632     
Goodwill26,713     
Intangible assets, net (excluding goodwill)252,919     
Deferred income tax assets  17,32793,759154,171
Other noncurrent assets4,2991082143123737
Deferred tax assets, net196,054 
Other undisclosed noncurrent assets97,607111,430125,253139,076152,899166,722
Total noncurrent assets:787,986612,722657,512293,592349,150166,968
TOTAL ASSETS:1,231,497926,395999,570724,826548,193367,337
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,4744,7984,7084,8094,7458,242
Interest and dividends payable4,1524,1524,1524,2645,920
Employee-related liabilities6194906474701,721
Accounts payable2,93927661011601
Accrued liabilities12,535     
Deferred revenue2,094   
Debt 96,193     
Other liabilities21,2071,0091,4025629551,500
Other undisclosed current liabilities      25,000
Total current liabilities:134,9685,8076,1105,3715,70034,742
Noncurrent Liabilities
Long-term debt and lease obligation444,180394,653385,517377,120382,855574,362
Long-term debt, excluding current maturities444,180394,653385,517377,120382,855574,362
Liabilities, other than long-term debt76,689 106219586940
Deferred income tax liabilities5,771   
Other liabilities70,918 106219586940
Other undisclosed noncurrent liabilities9,872     
Total noncurrent liabilities:530,741394,653385,623377,339383,441575,302
Total liabilities:665,709400,460391,733382,710389,141610,044
Equity
Equity, attributable to parent565,788414,743539,912313,495153,583(242,859)
Common stock6926961,0141,0131,0111,019
Treasury stock, value(393,829)(393,829)   (3,263)
Additional paid in capital1,163,8361,264,0241,260,9001,258,8591,256,2671,258,151
Accumulated other comprehensive income (loss)    27(3)(18)
Accumulated deficit(204,911)(456,148)(722,002)(946,404)(1,103,692)(1,498,748)
Equity, attributable to noncontrolling interest  111,19267,92528,6215,469152
Total equity:565,788525,935607,837342,116159,052(242,707)
TOTAL LIABILITIES AND EQUITY:1,231,497926,395999,570724,826548,193367,337

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues331,339391,866336,794261,016261,004217,217
Gross profit:331,339391,866336,794261,016261,004217,217
Operating expenses(110,551)(16,763)(15,671)(14,656)(22,753)(33,613)
Operating income:220,788375,103321,123246,360238,251183,604
Nonoperating income (expense)263,32387,40451,4535,195(4,042)(5,731)
Investment income, nonoperating 266,69691,03051,8015,5401,6601,311
Other nonoperating expense(3,373)(3,626)(348)(345)(5,702)(7,042)
Interest and debt expense(36,451)(19,070)(18,331)(18,660)(23,954)(43,601)
Income from continuing operations before equity method investments, income taxes:447,660443,437354,245232,895210,255134,272
Income (loss) from equity method investments(161,749)     
Other undisclosed income (loss) from continuing operations before income taxes1,0381,839    
Income from continuing operations before income taxes:286,949445,276354,245232,895210,255134,272
Income tax expense (benefit)(66,687)(76,439)(60,431)(41,902)196,073 
Income from continuing operations:220,262368,837293,814190,993406,328134,272
Income before gain (loss) on sale of properties:368,837293,814190,993406,328134,272
Net income:220,262368,837293,814190,993406,328134,272
Net loss attributable to noncontrolling interest (6,341)(102,983)(69,412)(33,705)(11,272)(129)
Net income available to common stockholders, basic:213,921265,854224,402157,288395,056134,143
Interest on convertible debt  4,7364,7174,6485,6615,647
Other undisclosed net income available to common stockholders, diluted11,648     
Net income available to common stockholders, diluted:225,569270,590229,119161,936400,717139,790

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income:220,262368,837293,814190,993406,328134,272
Other undisclosed comprehensive income (loss)   (27)3015(19)
Comprehensive income:220,262368,837293,787191,023406,343134,253
Comprehensive loss, net of tax, attributable to noncontrolling interest (6,341)(102,983)(69,412)(33,705)(11,272)(129)
Comprehensive income, net of tax, attributable to parent:213,921265,854224,375157,318395,071134,124

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: